Andrew Morrison
Family Medicine · Brea, CANPI 1750382628
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.2% of the total across 153 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 27 manufacturers reported payments, led by AstraZeneca at 24.6% of the total. Reporting peaked in 2019 at $3,353 and has fallen 78.1% since, to $735 in 2025. Among family medicine clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 153 payments — averaging $35.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- GSK$811
- Lilly USA, LLC$487
- Novo Nordisk$468
- Pfizer$406
- Amgen$384
- plus $1K from 21 others
What the payments were for
- Consulting fees$200%
- Food & beverage$5,32799%
- Education$230%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 33 | $1,320 |
| GSK | 15 | $811 |
| Lilly USA, LLC | 13 | $487 |
| Novo Nordisk | 11 | $468 |
| Pfizer | 20 | $406 |
| Amgen | 11 | $384 |
| AbbVie | 4 | $286 |
| Johnson & Johnson | 7 | $187 |
| Merck | 7 | $185 |
| Kowa Pharmaceuticals America, Inc. | 2 | $153 |
| Mayne Pharma Commercial LLC | 1 | $125 |
| Astellas Pharma US Inc | 5 | $105 |
| Kaleo, Inc. | 4 | $61 |
| Boehringer Ingelheim | 3 | $57 |
| Amarin Pharma, Inc. | 2 | $46 |
| Bausch Health US, LLC | 2 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $39 |
| Sanofi Pasteur Inc. | 2 | $37 |
| Shire North American Group Inc | 1 | $22 |
| Irhythm Technologies, Inc. | 1 | $22 |
| Therapeuticsmd, Inc. | 1 | $21 |
| Avanir Pharmaceuticals, Inc. | 1 | $21 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
| Spinal Simplicity, LLC | 1 | $17 |
| AMAG Pharmaceuticals, Inc. | 1 | $17 |
| Nalpropion Pharmaceuticals LLC | 1 | $16 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,369 in reported general payments places this provider in the 90th percentile of 10,533 family medicine providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 34 | $444 |
| Rosuvastatin Calcium | 17 | $303 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Brea
- Dennis ShultsBrea$287K
- Sherly SoleimanEncino$1.2M
- Pamela KushnerLos Angeles$1.2M
- Sujata NarayanStanford$1.2M
- Jeffrey UngerChino$906K
- Alexander RivkinLos Angeles$866K
- Scott HowellLos Angeles$793K
- Derrick ButlerLos Angeles$692K
- Sandra CalmanMontara$589K
- Anthony JonesOakland$377K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.